Annual Cash & Cash Equivalents
$9.66 M
-$169.63 M-94.61%
December 31, 2023
Summary
- As of February 22, 2025, PYXS annual cash & cash equivalents is $9.66 million, with the most recent change of -$169.63 million (-94.61%) on December 31, 2023.
- During the last 3 years, PYXS annual cash & cash equivalents has risen by +$1.58 million (+19.60%).
- PYXS annual cash & cash equivalents is now -96.48% below its all-time high of $274.74 million, reached on December 31, 2021.
Performance
PYXS Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$12.06 M
-$13.02 M-51.92%
September 30, 2024
Summary
- As of February 22, 2025, PYXS quarterly cash and cash equivalents is $12.06 million, with the most recent change of -$13.02 million (-51.92%) on September 30, 2024.
- Over the past year, PYXS quarterly cash and cash equivalents has dropped by -$2.66 million (-18.07%).
- PYXS quarterly cash and cash equivalents is now -95.61% below its all-time high of $274.74 million, reached on December 31, 2021.
Performance
PYXS Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
PYXS Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -94.6% | -18.1% |
| 3 y3 years | +19.6% | -53.5% |
| 5 y5 years | -50.9% | -53.5% |
PYXS Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -96.5% | at low | -95.6% | +24.8% |
| 5 y | 5-year | -96.5% | +19.6% | -95.6% | +49.2% |
| alltime | all time | -96.5% | +19.6% | -95.6% | +49.2% |
Pyxis Oncology Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $12.06 M(-51.9%) |
| Jun 2024 | - | $25.07 M(-10.3%) |
| Mar 2024 | - | $27.97 M(+189.4%) |
| Dec 2023 | $9.66 M(-94.6%) | $9.66 M(-34.3%) |
| Sep 2023 | - | $14.71 M(-43.2%) |
| Jun 2023 | - | $25.90 M(-51.2%) |
| Mar 2023 | - | $53.06 M(-70.4%) |
| Dec 2022 | $179.29 M | $179.29 M(-9.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $198.54 M(-11.1%) |
| Jun 2022 | - | $223.35 M(-9.6%) |
| Mar 2022 | - | $247.09 M(-10.1%) |
| Dec 2021 | $274.74 M(+3300.2%) | $274.74 M(+105.8%) |
| Sep 2021 | - | $133.48 M(-6.3%) |
| Jun 2021 | - | $142.47 M(+1663.3%) |
| Dec 2020 | $8.08 M(-59.0%) | $8.08 M |
| Dec 2019 | $19.69 M | - |
FAQ
- What is Pyxis Oncology annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Pyxis Oncology?
- What is Pyxis Oncology annual cash & cash equivalents year-on-year change?
- What is Pyxis Oncology quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Pyxis Oncology?
- What is Pyxis Oncology quarterly cash and cash equivalents year-on-year change?
What is Pyxis Oncology annual cash & cash equivalents?
The current annual cash & cash equivalents of PYXS is $9.66 M
What is the all time high annual cash & cash equivalents for Pyxis Oncology?
Pyxis Oncology all-time high annual cash & cash equivalents is $274.74 M
What is Pyxis Oncology annual cash & cash equivalents year-on-year change?
Over the past year, PYXS annual cash & cash equivalents has changed by -$169.63 M (-94.61%)
What is Pyxis Oncology quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of PYXS is $12.06 M
What is the all time high quarterly cash and cash equivalents for Pyxis Oncology?
Pyxis Oncology all-time high quarterly cash and cash equivalents is $274.74 M
What is Pyxis Oncology quarterly cash and cash equivalents year-on-year change?
Over the past year, PYXS quarterly cash and cash equivalents has changed by -$2.66 M (-18.07%)